Nakamura, Kimihiko
Isoyama, Naohito
Nakayama, Yuki
Hiroyoshi, Toshiya
Fujikawa, Koki
Miura, Yutaka
Kurosu, Hiroshi
Matsuyama, Hideyasu
Kuro-o, Makoto
Funding for this research was provided by:
Japan Agency for Medical Research and Development (ACT-M)
Article History
Received: 15 March 2022
Accepted: 25 July 2022
First Online: 29 July 2022
Competing interests
: Hideyasu Matsuyama received honoraria for lectures from Yanssen Pharma, Chugai, Bayer, AstraZeneka, and MSD, and research funding from Astellas, Yanssen Pharma, Baxter, Kyowa-Kirin, Takeda, and Sanofi. Makoto Kuro-o received honoraria for lectures from Bayer Japan and research funding from Kaneka Co., Kissei Pharmaceutical Co., and Ovibio.